Mednax Q2: GAAP EPS $0.36, adj EPS $0.41, revenue $473M (+14% YoY), volume strong

Pediatrix Medical Group, Inc.

2021-Q2 EPS reported $0.61 revenue$919,712,000

Net revenue $473M vs $415.4M prior year; income from cont ops $30.5M ($0.36 diluted) vs $7.1M ($0.08).
Adjusted EPS $0.41 vs $0.26; adjusted EBITDA $65.5M vs $55.7M.
Same-unit revenue +13.4% (volume +9.5%, reimbursement +3.9%); office-based services volume +23.2%.
No CARES Act funds in Q2'21 vs $5.8M in Q2'20; gain on building sale $7.3M excluded from adj metrics.
Redeemed $750M 5.25% notes due 2023 in Jan 2021; debt now $1.0B with no revolver borrowings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.